| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.0M | -15.3% |
| R&D Expense | $168.5M | +29.4% |
| SG&A Expense | $58.1M | +37.0% |
| Operating Income | -$222.6M | -32.6% |
| Pre-tax Income | -$214.5M | -30.9% |
| Income Tax | $0 | — |
| Net Income | -$214.5M | -30.9% |
| EPS (Basic) | -$3.69 | -17.1% |
| EPS (Diluted) | -$3.69 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $54.9M | +68.0% |
| Short-term Investments | $503.7M | +66.9% |
| Current Assets | $574.2M | +66.3% |
| Total Assets | $635.4M | +80.4% |
| Current Liabilities | $43.9M | +58.5% |
| Total Liabilities | $96.2M | +168.5% |
| Stockholders' Equity | $539.1M | +70.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$166.3M | -44.4% |
| Capital Expenditures | $4.7M | +183.1% |
| Investing Cash Flow | -$200.4M | -15.2% |
| Financing Cash Flow | $388.9M | +218.9% |
| Free Cash Flow | -$171.0M | -46.3% |
| -17.1% |